Literature DB >> 24833085

Pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.

Joe Spencer Liles1, Matthew H G Katz.   

Abstract

Traditionally, pancreatic ductal adenocarcinoma with regional vascular involvement was thought to represent unresectable disease and was associated with disease progression and death within 1 year of diagnosis. Recent evidence demonstrates that pancreaticoduodenectomy with vascular resection and reconstruction can be safely performed in select patients with 5-year survival rates as high as 20%. In order to safely treat and to optimize survival in these complex patients, it is essential to accurately identify vascular involvement preoperatively, to utilize a multidisciplinary treatment approach, and to emphasize meticulous surgical technique with awareness of the critical margins of resection.

Entities:  

Keywords:  celiac axis; hepatic artery; multimodality therapy; pancreatic adenocarcinoma; portal vein; superior mesenteric artery; superior mesenteric vein; vascular involvement; vascular resection

Mesh:

Year:  2014        PMID: 24833085     DOI: 10.1586/14737140.2014.919860

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  7 in total

1.  Surgical, survival, and oncological outcomes after vascular resection in robotic and open pancreaticoduodenectomy.

Authors:  Bor-Uei Shyr; Shih-Chin Chen; Yi-Ming Shyr; Shin-E Wang
Journal:  Surg Endosc       Date:  2019-04-08       Impact factor: 4.584

Review 2.  Management of borderline resectable pancreatic cancer.

Authors:  Amit Mahipal; Jessica Frakes; Sarah Hoffe; Richard Kim
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

3.  Use of the peritoneum or the round ligament of the liver in radical surgery for pancreatic cancer.

Authors:  Zhuoliang Zhang; Bo Zhou; Xiang Zheng; Pengfei Huang; Sheng Yan
Journal:  Gland Surg       Date:  2021-11

4.  Cold-stored cadaveric venous allograft for superior mesenteric/portal vein reconstruction during pancreatic surgery.

Authors:  Dyre Kleive; Audun E Berstad; Caroline S Verbeke; Sven P Haugvik; Ivar P Gladhaug; Pål-Dag Line; Knut J Labori
Journal:  HPB (Oxford)       Date:  2016-06-20       Impact factor: 3.647

Review 5.  Superior Mesenteric and Portal Vein Reconstruction With Cadaveric Allograft During Pancreatoduodenectomy - A Case Report and Literature Review.

Authors:  Nicolae Bacalbasa; Laura Iliescu; Iulian Brezean; Irina Balescu; Mihaela Vilcu; Simona Dima; Vladislav Brasoveanu; Irinel Popescu
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

6.  Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study.

Authors:  Dong S; Wang L; Guo Y B; Ying H F; Shen X H; Meng Z Q; Chen Hao; Chen Q W; Li Z S
Journal:  World J Surg Oncol       Date:  2017-07-03       Impact factor: 2.754

7.  Survival outcomes of pancreaticoduodenectomy versus extended pancreaticoduodenectomy procedure for pancreatic head carcinoma: a propensity score matching study.

Authors:  Ning Pu; Sucheng Mu; Yuan Fang; Hanlin Yin; Gao Liu; Guochao Zhao; Lei Zhang; Wenchuan Wu; Wenhui Lou
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.